JPH02121924A - 制癌剤効果増強剤 - Google Patents

制癌剤効果増強剤

Info

Publication number
JPH02121924A
JPH02121924A JP27445088A JP27445088A JPH02121924A JP H02121924 A JPH02121924 A JP H02121924A JP 27445088 A JP27445088 A JP 27445088A JP 27445088 A JP27445088 A JP 27445088A JP H02121924 A JPH02121924 A JP H02121924A
Authority
JP
Japan
Prior art keywords
group
cancer
anticancer drug
anticancer
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP27445088A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0565487B2 (enExample
Inventor
Nobuyuki Fukazawa
深澤　信幸
Makoto Odate
尾舘　誠
Tsuneshi Suzuki
常司 鈴木
Takashi Tsuruo
隆 鶴尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Mitsui Toatsu Chemicals Inc
Original Assignee
Japanese Foundation for Cancer Research
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Mitsui Toatsu Chemicals Inc filed Critical Japanese Foundation for Cancer Research
Priority to JP27445088A priority Critical patent/JPH02121924A/ja
Publication of JPH02121924A publication Critical patent/JPH02121924A/ja
Publication of JPH0565487B2 publication Critical patent/JPH0565487B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
JP27445088A 1988-11-01 1988-11-01 制癌剤効果増強剤 Granted JPH02121924A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27445088A JPH02121924A (ja) 1988-11-01 1988-11-01 制癌剤効果増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27445088A JPH02121924A (ja) 1988-11-01 1988-11-01 制癌剤効果増強剤

Publications (2)

Publication Number Publication Date
JPH02121924A true JPH02121924A (ja) 1990-05-09
JPH0565487B2 JPH0565487B2 (enExample) 1993-09-17

Family

ID=17541861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27445088A Granted JPH02121924A (ja) 1988-11-01 1988-11-01 制癌剤効果増強剤

Country Status (1)

Country Link
JP (1) JPH02121924A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022846A1 (en) * 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022846A1 (en) * 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents

Also Published As

Publication number Publication date
JPH0565487B2 (enExample) 1993-09-17

Similar Documents

Publication Publication Date Title
WO2021073439A1 (zh) 用于抑制shp2活性的吡嗪衍生物
TWI718113B (zh) 吡啶甲醯胺類衍生物、其製備方法及其在醫藥上的應用
TWI822666B (zh) Ｊａｎｕｓ激酶抑制劑之結晶型
EP3858833B1 (en) Aminonorbornane derivative and manufacture method thereof and use thereof
WO2021057867A1 (zh) 一类基于有机胂的cdk抑制剂及其制备方法和用途
HUE031999T2 (en) Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
CN105693624B (zh) 马西替坦晶体及其制备方法、其药物组合物和用途
CN106810582A (zh) 吡喃葡萄糖基衍生物的复合物、制备方法和应用
WO2021088992A1 (zh) 作为prmt5抑制剂的四氢异喹啉螺环化合物
WO2023165165A1 (zh) 靶向a2a的苯并咪唑并吡嗪-3-甲酰胺及其肿瘤免疫功能
CN108239123A (zh) 吡喃葡萄糖基衍生物的共晶、制备方法和应用
WO2020238776A1 (zh) 取代的稠合双环类衍生物、其制备方法及其在医药上的应用
MX2015003607A (es) Medios y metodo para el tratamiento de tumores solidos.
US8344017B2 (en) Anti-hepatitis C virus agents and anti-HIV agents
JP3076672B2 (ja) キノリン誘導体のフマル酸塩
CN107207476A (zh) 吲哚和氮杂吲哚衍生物及其用于神经退化性疾病中的用途
JPH02121924A (ja) 制癌剤効果増強剤
CN109111439B (zh) 一种酰胺类化合物及包含该化合物的组合物及其用途
CN111825608A (zh) 四氢喹啉类与四氢异喹啉类化合物及其用途
KR20230157471A (ko) 화합물의 다형체 및 이의 제조방법과 용도
JP2781073B2 (ja) 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
CN104513188A (zh) 一种氰基吡咯烷类衍生物及其制备方法和应用
CN116535390B (zh) pH敏感型4-酰胺哌啶类衍生物、药物组合物及其制备方法和应用
CA2570818A1 (en) Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands
JPH04356466A (ja) 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090917

Year of fee payment: 16

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090917

Year of fee payment: 16